| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/24/2010 | EP1636225B1 Pyridino 1,2-a pyrimidin-4-one compounds as anticancer agents |
| 02/24/2010 | EP1625121B1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/24/2010 | EP1615615B1 Tamper-resistant products for opioid delivery |
| 02/24/2010 | EP1605976B1 PHENYLCARBOXYL ACID AMIDES AND IK r CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA |
| 02/24/2010 | EP1585728B1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases |
| 02/24/2010 | EP1572066B1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 02/24/2010 | EP1553962B1 Combination chemotherapy with chlorotoxin |
| 02/24/2010 | EP1542678B1 1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE DERIVATIVES AS CANNABINOID-CB sb 1 /sb RECEPTOR LIGANDS |
| 02/24/2010 | EP1501774B9 Polyunsaturated linear aldehydes and their derivatives with anti-radical activity |
| 02/24/2010 | EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 02/24/2010 | EP1461316B1 Synthesis of 2-cyanoziridine-1-carboxamide |
| 02/24/2010 | EP1294422B1 Medical System for Reducing Vascular Occlusions |
| 02/24/2010 | EP1200607B1 Tet repressor-based transcriptional regulatory proteins |
| 02/24/2010 | EP1033979B2 Combination of cyp2a6 enzyme inhibitors and nicotine and their therapeutic use |
| 02/24/2010 | EP0861261B9 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 02/24/2010 | CN201410116Y Amoxicillin and sulbactam pivoxil dual-release capsule |
| 02/24/2010 | CN201409610Y Medicine toothbrush |
| 02/24/2010 | CN101657204A Use of lipid conjugates in the treatment of diseases or disorders of the eye |
| 02/24/2010 | CN101657203A Compositions and methods for delivery of anti-cancer agents |
| 02/24/2010 | CN101657202A D-ribose for treating suboptimal pulmonary function |
| 02/24/2010 | CN101657200A Novel ss-lactam antibiotics, method for the production thereof, and use thereof |
| 02/24/2010 | CN101657199A Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy |
| 02/24/2010 | CN101657198A ranolazine for enhancing insulin secretion |
| 02/24/2010 | CN101657197A Use of fungicides for treating fish mycoses |
| 02/24/2010 | CN101657196A Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof |
| 02/24/2010 | CN101657195A Novel crystal of (S)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
| 02/24/2010 | CN101657194A Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and a process thereof |
| 02/24/2010 | CN101657193A Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia |
| 02/24/2010 | CN101657192A Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
| 02/24/2010 | CN101657191A Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma |
| 02/24/2010 | CN101654673A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654672A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN101654470A Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof |
| 02/24/2010 | CN101653604A Anti-ngf antibodies for the treatment of various disorders |
| 02/24/2010 | CN101653451A Health product for keeping joint health and increasing bone density and preparation method thereof |
| 02/24/2010 | CN101653450A Improved dietary fiber containing materials comprising low molecular weight glucan |
| 02/24/2010 | CN101653449A Application of ADDA and/or DMTA in preparing medicine for improving expression level of gamma-globin |
| 02/24/2010 | CN101653448A Veterinary compound terramycin injection and preparation method thereof |
| 02/24/2010 | CN101653447A Application of protopanoxadiol type saponin in pseudo-qinseng in preparing antiatherosclerotics |
| 02/24/2010 | CN101653446A Composition for treating chicken necrotizing enterocolitis and preparation method thereof |
| 02/24/2010 | CN101653445A Application of tyrosol galactoside in preparing anoxia-resistant and anti-fatigue medicament |
| 02/24/2010 | CN101653444A Preparation series for treating ischemic stroke and production tehcnique |
| 02/24/2010 | CN101653443A Composition of amino-cephalosporanic acid and arginine |
| 02/24/2010 | CN101653442A Application of fluorouracil injection and compound in treating steatocystoma multiplex |
| 02/24/2010 | CN101653441A Veterinary compound florfenicol injection and preparation method thereof |
| 02/24/2010 | CN101653440A Treatment composition containing amlodipine series salt and pril medicament |
| 02/24/2010 | CN101653439A Application of C60-benzoic nitrogen mustard in preparing antitumor medicament |
| 02/24/2010 | CN101653438A Application of calycosin in radix astragali in preparing medicament for vascular protection and angiogenesis promotion |
| 02/24/2010 | CN101653437A Novel application of sulfonic benzo-gamma-pyrone compound |
| 02/24/2010 | CN101653436A Omega-3 fatty acids for the treatment of canine ostheoarthritis |
| 02/24/2010 | CN101653435A Sanitizer and preparation method and application thereof |
| 02/24/2010 | CN101653434A Vitamin composition for promoting growth of meat chicks |
| 02/24/2010 | CN101653433A Vitamin composition for improving production performance of breeding hens |
| 02/24/2010 | CN101653432A Vitamin composition for growing-finishing pigs |
| 02/24/2010 | CN101653424A 高药物载荷片剂 High drug load tablets |
| 02/24/2010 | CN101653421A Compositions comprising pectin and ascorbic acid |
| 02/24/2010 | CN101653411A Controlled release hydrocodone formulations |
| 02/24/2010 | CN101653354A Noninvasive measurements of chemical substances |
| 02/24/2010 | CN100591681C Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid |
| 02/24/2010 | CN100591666C 2-(1h-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 02/24/2010 | CN100591356C Compositions containing nicorandil, preparation method and use |
| 02/24/2010 | CN100591355C Compositions for treating hyperproliferative conditions and its pharmaceutical uses |
| 02/24/2010 | CN100591334C Usage of eleutheroside with anti-inflammatory action or aglycone thereof |
| 02/24/2010 | CN100591333C Stable eye lotion containing latanoprost as active ingredient |
| 02/24/2010 | CN100591332C 7-carboxymethyloxy-3', 4', 5-trimethoxy flavone monohydrate, the preparation method and uses thereof |
| 02/24/2010 | CN100591331C Combination chemotherapy compositions |
| 02/24/2010 | CN100591329C Montelukast granule formulation |
| 02/24/2010 | CN100591328C Cosmetic compositions containing chick pea extract and retinoids |
| 02/24/2010 | CN100591320C Stable surfactant compositions for suspending components |
| 02/24/2010 | CN100591225C Composition containing isoflavone of high concentration and having high solubility, and process for producing the same |
| 02/23/2010 | USRE41151 Comprising a modified NSAID, wherein the NSAID is covalently attached either directly or through a linker molecule to a sulfur-containing functional group containing an optionally substituted hydrocarbyl moiety; nonsteroidal anti-inflammatory drugs; side-effect reduction |
| 02/23/2010 | USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
| 02/23/2010 | USRE41149 Optically active pyridonecarboxylic acid derivatives |
| 02/23/2010 | USRE41148 Comprising an immediate-release component and an enteric delayed-release component; amphetamine aspartate and sulfate salts, dextroamphetamine saccharate or sulfate salts; FDA listed patent for Adderall XR 10 |
| 02/23/2010 | US7667077 Poly-halogenated triazapentadiene compositions |
| 02/23/2010 | US7667069 ointment or eyedrops; addition of maleic acid, dissolved in a suitable organic solvent, to ibopamine base |
| 02/23/2010 | US7667057 Cosmetic composition comprising a complex of cyclodextrin and vitamin F |
| 02/23/2010 | US7667053 Cannabinoid-1 (CB1) receptor antagonists and/or inverse agonists; e.g. N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-1,4-benzodioxane-2-carboxamide; psychological disorders, eating disorders |
| 02/23/2010 | US7667052 Bioactive substance |
| 02/23/2010 | US7667044 treating nervous system diorders such as Alzheimer's disease, Down Syndrome, Parkinson disease and Huntington chorea by administering inhibitors of prolyl endopeptidases |
| 02/23/2010 | US7667041 Cinnamide compound |
| 02/23/2010 | US7667040 Azacyclic ethynyl derivatives |
| 02/23/2010 | US7667037 Processes for preparation of ziprasidone |
| 02/23/2010 | US7667036 Pyrazolo[1,5-a]pyrimidine derivatives |
| 02/23/2010 | US7667035 (R)-2-(-3-amino-piperidin-1-yl)-3-(but-2-ynyl)-5-(4-methyl-quinazolin-2-ylmethyl)-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibitors of dipeptidylpeptidase IV (DPP IV) |
| 02/23/2010 | US7667027 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β) |
| 02/23/2010 | US7667015 Genetic engineering; induce immunology response; biodrug as anticarcinogenic agents, for pancreatic cancer |
| 02/23/2010 | US7667013 Gene encoding a guanine nucleotide exchange factor and the gene product thereof |
| 02/23/2010 | US7667012 Condensation of a specifically engineered phosphine containing a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine by-product and producing an amide bond in final product; N-azidogalactosamine |
| 02/23/2010 | US7666999 Neutral amino acid transporter and gene thereof |
| 02/23/2010 | US7666913 And isotaxiresinol ether, ester and/or salt analogs; not only inhibits bone resorption but also improves bone formation; plant extracts; lignins; nontoxic; bone disorders |
| 02/23/2010 | US7666912 Compositions and methods for reducing body fat |
| 02/23/2010 | US7666911 Self assembled nanostructures and methods for preparing the same |
| 02/23/2010 | US7666910 Locating an artery which carries major blood supply to the tumor; intra-arterially injecting into the located artery a predetermined quantity of a polyunsaturated fatty acid solution and anti-antiogenic substances |
| 02/23/2010 | US7666909 Enhancement of alcohol metabolism |
| 02/23/2010 | US7666906 β-Benzyloxyaspartate derivatives with amino group on benzene ring |
| 02/23/2010 | US7666905 Compositions comprising hepoxilin analogs and their use in the treatment of cancer |
| 02/23/2010 | US7666904 3-aryl-4-hydroxyfuranone compounds and the human and animal health use thereof |
| 02/23/2010 | US7666903 Reaction products of 2-propylheptanol with 1-halogen-2,3-epoxypropanes and 1-hydroxy-2,3-epoxypropane |